Studies have reported that increased CSF MCP-1 levels are linked to lower MMSE scores, and greater baseline levels predict a faster rate of cognitive deterioration in the early stages of Alzheimer’s disease [24]. This evidence concerns the gene CCL2 and Alzheimer disease.